Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 19/20 | 0.70 |
| ▸ | SLC5A1 | P13866 | 12/20 | 0.70 |
| ▸ | HTR6 | P50406 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26790147 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1HTR6 | |
| SCHEMBL27085163 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1HTR6 | |
| SCHEMBL26790211 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1HTR6 | |
| SCHEMBL26792799 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1HTR6 | |
| SCHEMBL26795589 | 0.91 | SLC5A2 (0.68) | SLC5A2SLC5A1 | |
| SCHEMBL27084747 | 0.90 | SLC5A2 (0.69) | SLC5A2SLC5A1 | |
| SCHEMBL27084726 | 0.90 | SLC5A2 (0.66) | SLC5A2SLC5A1 | |
| SCHEMBL26790367 | 0.90 | SLC5A2 (0.66) | SLC5A2SLC5A1 | |
| SCHEMBL26790344 | 0.90 | SLC5A2 (0.66) | SLC5A2SLC5A1 | |
| SCHEMBL27085097 | 0.90 | SLC5A2 (0.69) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085040-A1 | AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES | BIONXT SOLUTIONS INC (CA) | 2026-03-26 | — | — | US | disclosed |
| EP-4587449-A1 | AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES | Bionxt Solutions Inc. (CA) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024055106-A1 | AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES | BIONXT SOLUTIONS INC. (CA) | 2024-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085040-A1 | AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES | UGCG, PNMT, GALC | SLC5A2 131/4885SLC5A1 127/4885HTR6 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.